Brean Murray Carret & Co.'s Buy rating on Ardea Biosciences (NASDAQ: RDEA) remains as the firm raises their price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE